Randomized Phase II Trials: Inevitable or Inadvisable? Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 20, 2010
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Clinical Trials, Phase II as Topic (MeSH)
- Humans (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Randomized Controlled Trials as Topic (MeSH)
- Research Design (MeSH)
published in
- Journal of Clinical Oncology Journal